Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb;14(2):300-308.
doi: 10.1080/17441692.2018.1505933. Epub 2018 Aug 7.

Barriers and facilitators to PrEP for transwomen in Brazil

Erin C Wilson  1 , Emilia M Jalil  2 , Cristiane Castro  2 , Nilo Martinez Fernandez  2 , Luciana Kamel  2 , Beatriz Grinsztejn  2
Affiliations

Barriers and facilitators to PrEP for transwomen in Brazil

Erin C Wilson et al. Glob Public Health. 2019 Feb.

Abstract

Pre-exposure prophylaxis (PrEP) is an important biomedical intervention that may help reduce the risk of HIV transmission among transwomen. To date, little research is available to inform interventions to increase uptake and adherence to PrEP among transwomen, especially in places outside the U.S. We conducted a qualitative study in 2015 with 34 adult transwomen in Rio de Janeiro, Brazil and assessed awareness, interest, barriers and facilitators to PrEP uptake and adherence for transwomen. Almost one third of participants had heard of PrEP, and most were interested and thought it would be beneficial for transwomen in their community. Barriers to PrEP included fear of being HIV positive resulting in low HIV testing and concerns about the ability to adhere to a daily PrEP regimen. The most prominent barrier to uptake was past experiences of transgender-identity related discrimination in the universal health care system that reduced willingness to seek PrEP or health care in general. Participants recommended technological solutions to PrEP health education information that could address uptake and adherence. This study informs efforts to increase PrEP use among transwomen in Brazil.

Keywords: Brazil; HIV prevention; Pre exposure prophylaxis; transgender women.

PubMed Disclaimer

Conflict of interest statement

Disclosure Statement

There are no conflicts of interest.

References

    1. (CDC), C. f. D. C. a. P. (2018). Pre-exposure Prophylaxis (PrEP) Retrieved Date Accessed, 2018 from https://www.cdc.gov/hiv/risk/prep/index.html.
    1. Baral SD, Poteat T, Stromdahl S, Wirtz AL, Guadamuz TE, & Beyrer C (2013). Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis, 13(3), pp. 214–222. doi:10.1016/S1473-3099(12)70315-8 Retrieved from 10.1016/S1473-3099(12)70315-8http://www.ncbi.nlm.nih.gov/pubmed/23260128 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23260128 - DOI - PubMed
    1. Carlo Hojilla J, Koester KA, Cohen SE, Buchbinder S, Ladzekpo D, Matheson T, & Liu AY (2016). Sexual Behavior, Risk Compensation, and HIV Prevention Strategies Among Participants in the San Francisco PrEP Demonstration Project: A Qualitative Analysis of Counseling Notes. AIDS Behav, 20(7), pp. 1461–1469. doi:10.1007/s10461-015-1055-5 Retrieved from 10.1007/s10461-015-1055-5https://www.ncbi.nlm.nih.gov/pubmed/25835463 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/25835463 - DOI - PMC - PubMed
    1. Costa AB, da Rosa Filho HT, Pase PF, Fontanari AMV, Catelan RF, Mueller A, … Koller SH (2018). Healthcare Needs of and Access Barriers for Brazilian Transgender and Gender Diverse People. J Immigr Minor Health, 20(1), pp. 115–123. doi:10.1007/s10903-016-0527-7 Retrieved from 10.1007/s10903-016-0527-7http://www.ncbi.nlm.nih.gov/pubmed/27804013 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27804013 - DOI - PubMed
    1. Deutsch MB, Glidden DV, Sevelius J, Keatley J, McMahan V, Guanira J, … iPrEx, i. (2015). HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV, 2(12), pp. e512–519. doi:10.1016/S2352-3018(15)00206-4 Retrieved from 10.1016/S2352-3018(15)00206-4http://www.ncbi.nlm.nih.gov/pubmed/26614965 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26614965 - DOI - PMC - PubMed

Publication types